Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Meijboom RW"'
Autor:
Meijboom RW; Pharmacy Foundation of Haarlem Hospitals, Haarlem, the Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland., Becker ML; Pharmacy Foundation of Haarlem Hospitals, Haarlem, the Netherlands.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem, the Netherlands., Movig KLL; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, the Netherlands., Kuijvenhoven J; Department of Gastroenterology and Hepatology, Spaarne Gasthuis, Haarlem, the Netherlands., Egberts TCG; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands., Giezen TJ; Pharmacy Foundation of Haarlem Hospitals, Boerhaavelaan 24, Haarlem 2035 RC, the Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem, the Netherlands.
Publikováno v:
Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2023 Sep 11; Vol. 16, pp. 17562848231197923. Date of Electronic Publication: 2023 Sep 11 (Print Publication: 2023).
Autor:
Meijboom RW; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands., Barbier L; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Druedahl LC; Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Copenhagen, Denmark., Sarnola K; Research at Kela, Social Insurance Institution of Finland (Kela), Helsinki, Finland., Tolonen HM; HUS Pharmacy, HUS Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.; Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Giezen TJ; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2023 Jul-Dec; Vol. 23 (8), pp. 801-817. Date of Electronic Publication: 2023 Mar 23.
Autor:
Meijboom RW; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands., Giezen TJ; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands. tgiezen@sahz.nl.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. tgiezen@sahz.nl.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands. tgiezen@sahz.nl.
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2022 Jan; Vol. 36 (1), pp. 27-39. Date of Electronic Publication: 2021 Dec 06.
Autor:
Meijboom RW; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland., Becker ML; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands., Ten Wolde S; Department of Rheumatology, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Giezen TJ; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands. tgiezen@sahz.nl.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. tgiezen@sahz.nl.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands. tgiezen@sahz.nl.
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2021 Nov; Vol. 35 (6), pp. 765-772. Date of Electronic Publication: 2021 Oct 26.
Autor:
Meijboom RW; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands., Gardarsdottir H; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland., Becker ML; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem and Hoofddorp, Haarlem, The Netherlands., de Groot MCH; Central Diagnostic Laboratory, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands., Movig KLL; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands., Kuijvenhoven J; Department of Gastroenterology and Hepatology, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Leufkens HGM; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands., Giezen TJ; Pharmacy Foundation of Haarlem Hospitals, Haarlem, The Netherlands.; Department of Clinical Pharmacy, Spaarne Gasthuis, Haarlem and Hoofddorp, Haarlem, The Netherlands.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2021 Aug; Vol. 9 (4), pp. e00843.
Autor:
Meijboom RW; Midden-Brabant Hospital Pharmacy, Elisabeth-TweeSteden Hospital, Dr. Deelenlaan 5, 5042 AD, Tilburg, The Netherlands. r.meijboom@etz.nl., Grootens KP; Reinier van Arkel Mental Health Institute, 's Hertogenbosch, The Netherlands.; Radboud University Medical Centre, Nijmegen, The Netherlands.
Publikováno v:
CNS drugs [CNS Drugs] 2017 Nov; Vol. 31 (11), pp. 939-957.